Paulex Bio Inc.

Pharmaceutical company · La Jolla, California, United States

Paulex Bio Inc. is a pharmaceutical company headquartered in La Jolla, California, United States. Its earliest recorded incorporation is in 2023. It has received 1 NIH small-business research grant, $350,000 in total. It has reported private securities offerings to the US SEC, most recently $19 million sold in a notice filed in 2025.

Profile compiled from public records. Is this your company? Request a correction or update

Paulex Bio at a glance

Typepharmaceutical company
HeadquartersLa Jolla, California, United States
Earliest incorporation on record2023
SEC CIK2071082

What does Paulex Bio do?

US government research funding

1 NIH small-business research grant, $350,000 in total. NIH funding came from the National Institute of Diabetes and Digestive and Kidney Diseases.

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $18.5 million sold (2025).

Frequently asked questions about Paulex Bio

Where is Paulex Bio headquartered?

Paulex Bio Inc. is headquartered in La Jolla, California, United States.

What does Paulex Bio do?

Paulex Bio Inc. is a pharmaceutical company.

When was Paulex Bio founded?

The earliest incorporation on record for Paulex Bio Inc. is in 2023, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences